Bayer HealthCare Rapidlab 800 - Manual (Page 555)

Performance Characteristics EĆ29
Substance Concentration Tested
Thiocyanate 80 mg/dL
Bilirubin (Direct) 30 mg/dL
Bilirubin (Total) 34 mg/dL
Creatinine 30 mg/dL
Hydroxybutyrate 200 mg/dL
Lactate 100 mg/dL
Urea 500 mg/dL
Uric Acid 10 mg/dL
* Interference by dopamine and structurally related drugs is dependent on glucose concentration. However,
even at high glucose concentrations, therapeutic levels of dopamine do not interfere with the glucose
measurement.
The following anticoagulants were found not to interfere with glucose recovery at
the indicated concentrations but they cannot be used on the 860 system due to
potential interferences on other sensors or analytes.
Table EĆ24.āăPotential Interference on Other Analytes
Substance Concentration Tested
Citrate 1000 mg/dL
Potassium Oxalate 1000 mg/dL
Refer to Sample Collection Devices and Anticoagulants in Section 1 for the specific
requirements on sample handling and anticoagulants.